INmune Bio is set to begin phase two human trials on a COVID-19 treatment in August that takes aim at what many scientists believe is the most lethal aspect of the virus.
"We think the primary problem is actually the blood clots," CEO Dr. Raymond J. Tesi told Cheddar on Thursday. "It's not the lungs. It's not the kidneys."
The small San Diego biotech company specializes in treating different types of inflammation, including another treatment that made headlines this week for showing promise in reducing brain inflammation in Alzheimer's patients. In the case of coronavirus, the company is developing a treatment that targets an immune response called the cytokine storm.
"The cytokine storm is basically a hyper-acute kind of inflammation that's like an atomic bomb going off in the patient," Tesi said. "In causing all of that inflammation, it causes all kinds of problems."
This is the same process that contributed to the high mortality rate of the Spanish Flu in 1918.
While COVID-19 was initially seen as a lung disease, it's now widely understood that it impacts every organ system in the body, Tesi said.
The virus itself is also less lethal than the outsized immune response that it causes in the body. This reaction can cause the inflammation of the endothelial cells — the lining or bricks that make up blood vessels — which can lead to blood clots.
"We believe that the key problem is actually something called the coagulopathy," Tesi said. "All these little blood clots form, and they break off and block the small blood vessels to things like the lung, the heart, the kidneys, the brain, you name it."
INmune's drug targets an immune protein called TNF that is found in inflamed tissue. Other companies have sought to block out the molecule altogether, while INmune pinpoints the most inflammatory form of the molecule, according to Tesi.
The phase two trial will treat 100 coronavirus patients with comorbidities or risk factors such as age, diabetes, and ethnic background, with the goal of treating them before they become intubated. The company is working closely with the FDA to develop the drug as quickly as possible, but Tesi did not provide a date for approving the drug and beginning mass distribution.
"The process of getting a phase two trial up and running a heavy lift for any company, but particularly a small company," he said.
Joe Cecela, Dream Exchange CEO, explains how they are aiming to form the first minority-controlled company to operate an exchange in U.S. history. Watch!
A Michigan judge is putting sponges in the hands of shoplifters and ordering them to wash cars in a Walmart parking lot when spring weather arrives. Genesee County Judge Jeffrey Clothier hopes the unusual form of community service discourages people from stealing from Walmart. The judge also wants to reward shoppers with free car washes. Clothier says he began ordering “Walmart wash” sentences this week for shoplifting at the store in Grand Blanc Township. He believes 75 to 100 people eventually will be ordered to wash cars this spring. Clothier says he will be washing cars alongside them when the time comes.
The State Department had been in talks with Elon Musk’s Tesla company to buy armored electric vehicles, but the plans have been put on hold by the Trump administration after reports emerged about a potential $400 million purchase. A State Department spokesperson said the electric car company owned by Musk was the only one that expressed interest back in May 2024. The deal with Tesla was only in its planning phases but it was forecast to be the largest contract of the year. It shows how some of his wealth has come and was still expected to come from taxpayers.
At 100 years old, the Goodyear Blimp is an ageless star in the sky. The 246-foot-long airship will be in the background of the Daytona 500 — flying roughly 1,500 feet above Daytona International Speedway, actually — to celebrate its greatest anniversary tour. Even though remote camera technologies are improving regularly and changing the landscape of aerial footage, the blimp continues to carve out a niche. At Daytona, with the usual 40-car field racing around a 2½-mile superspeedway, views from the blimp aptly provide the scope of the event.
You'll just have to wait for interest rates (and prices) to go down. Plus, this deal's a steel, the big carmaker wedding is off, and bribery is back, baby!
